These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 29557072

  • 1. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C, Yucel AA, Yesil TH, Kucuk H, Sezgin B, Mercan R, Yucel AE, Demirel GY.
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [Abstract] [Full Text] [Related]

  • 2. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H.
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [Abstract] [Full Text] [Related]

  • 3. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
    Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A.
    Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
    [Abstract] [Full Text] [Related]

  • 4. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F.
    Clin Exp Rheumatol; 2013 Apr; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [Abstract] [Full Text] [Related]

  • 5. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ, Park JS, Kang MI, Lee SK, Park YB, Lee SW.
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
    Na SY, Park MJ, Park S, Lee ES.
    Clin Exp Rheumatol; 2013 Dec; 31(3 Suppl 77):32-40. PubMed ID: 24064012
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
    Ahmadi M, Yousefi M, Abbaspour-Aghdam S, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Khabbazi A, Rostamzadeh D, Alipour S, Shabani M, Nouri M, Babaloo Z.
    J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum Cytokine Levels in Behçet's Disease.
    Akkurt ZM, Bozkurt M, Uçmak D, Yüksel H, Uçak H, Sula B, Gürsel Özkurt Z, Yildiz M, Akdeniz D, Arica M.
    J Clin Lab Anal; 2015 Jul; 29(4):317-20. PubMed ID: 25130392
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A.
    Clin Exp Rheumatol; 2010 Jul; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of the profile of CD4+ cells in Behçet's disease].
    Sugi N, Nakazawa M, Nakamura S, Minami M, Ohno S.
    Nippon Ganka Gakkai Zasshi; 1997 Apr; 101(4):335-40. PubMed ID: 9136573
    [Abstract] [Full Text] [Related]

  • 14. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A.
    Clin Exp Rheumatol; 2007 Apr; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [Abstract] [Full Text] [Related]

  • 15. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
    Aktas Cetin E, Cosan F, Cefle A, Deniz G.
    Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
    [Abstract] [Full Text] [Related]

  • 16. Cytokine profile in Behçet's disease patients. Relationship with disease activity.
    Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K.
    Scand J Rheumatol; 2002 Sep; 31(4):205-10. PubMed ID: 12369651
    [Abstract] [Full Text] [Related]

  • 17. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
    Shen H, Xia LP, Lu J.
    Scand J Rheumatol; 2013 Sep; 42(1):48-51. PubMed ID: 23101722
    [Abstract] [Full Text] [Related]

  • 18. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM, Lopalco G, Cantarini L, Emmi G, Lopalco A, Venerito V, Vitale A, Iannone F.
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [Abstract] [Full Text] [Related]

  • 19. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
    Ye Z, Wang C, Kijlstra A, Zhou X, Yang P.
    Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
    [Abstract] [Full Text] [Related]

  • 20. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
    Liu X, Yang P, Wang C, Li F, Kijlstra A.
    Rheumatology (Oxford); 2011 Feb; 50(2):293-8. PubMed ID: 21059671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.